Patent · US Active

Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

US12071484B2 · kind B2 · utility

0Cited by

22References

14Claims

0Family size

Assignee

CSL LIMITED · AU

Inventors

Andrew Donald Nash · Melbourne, AU
Arna Elizabeth Andrews · Melbourne, AU
Manuel Baca · Gaithersburg, US
Kirsten Mae Edwards · Melbourne, AU
Matthew HARDY · Whittlesea, AU
Con Panousis · Melbourne, AU
Felicity Meredith Dunlop · Melbourne, AU

Key dates

Filing date	Jul 9, 2020
Grant date	Aug 27, 2024
Priority date	—
Expiry date	Mar 18, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides proteins comprising antigen binding domains of antibodies that bind to human granulocyte-colony stimulating factor receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.